The Classification of Pre-invasive Lesions

Chapter
Part of the Molecular Pathology Library book series (MPLB, volume 6)

Abstract

This chapter discusses the three pre-invasive lesions recognised in the WHO classification of lung tumours. Squamous dysplasia and carcinoma in situ is a group of lesions recognised in the epithelium of bronchi. These lesions probably originate from hyperplasia of basal cells of the bronchial epithelium and ultimately may progress to invasive squamous cell carcinoma and possibly other bronchogenic tumours. Squamous dysplasia is classified in three grades; mild, moderate and severe dysplasia, with carcinoma in situ a separate, more advanced lesion. Distinct from central bronchial squamous carcinogenesis, atypical adenomatous hyperplasia (AAH) and adenocarcinoma in situ (AIS) are the pre-invasive lesions which define peripheral lung adenocarcinogenesis. These lesions arise from peripheral airway bronchiolo-alveolar epithelium, sometimes referred to as the terminal respiratory unit. AAH may be regarded as “dysplasia” arising in this epithelium and is a precursor of AIS, which then gives rise to peripheral type pulmonary adenocarcinoma. The least common, by far, of the pulmonary pre-invasive lesions is diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. A rare condition with an associated asthma-like syndrome, this condition is associated, in most examples, with the development of peripheral, spindle cell-type carcinoid tumours, hence its inclusion in the WHO classification.

Keywords

Adenocarcinoma Stratification Bronchiectasis Pneumoconiosis 

References

  1. 1.
    Travis WD, Brambilla E, Muller-Hermelink HK, et al., editors. World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.Google Scholar
  2. 2.
    Franklin WA, Wistuba II, Geisinger KR, et al. Squamous dysplasia and carcinoma in situ. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., editors. World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 68–72.Google Scholar
  3. 3.
    Kerr KM, Fraire AE, Pugatch B, et al. Atypical adenomatous hyperplasia. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., editors. World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 73–5.Google Scholar
  4. 4.
    Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244–85.PubMedCrossRefGoogle Scholar
  5. 5.
    Travis WD, Gosney JG. Diffuse pulmonary neuroendocrine cell hyperplasia. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al., editors. World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 76–8.Google Scholar
  6. 6.
    Ullman R, Bongiovanni M, Halbwedl I, et al. Bronchiolar columnar cell dysplasia—genetic analysis of a novel preneoplastic lesion of peripheral lung. Virchows Arch. 2003;442:429–36.Google Scholar
  7. 7.
    Pankiewicz W, Sulewska A, Niklinska W, et al. Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer. Folia Histochem Cytobiol. 2008;46:89–96.PubMedCrossRefGoogle Scholar
  8. 8.
    Kerr KM, Fraire AE. Pre-invasive diseases. In: Tomashefski J, Cagle P, Farver C, editors. Dail & Hammar’s pulmonary pathology. 3rd ed. New York: Springer; 2008. p. 158–215.CrossRefGoogle Scholar
  9. 9.
    Kerr KM. Pre-existing lung disease and lung cancer. In: Cagle PT, Allen TC, Dacic S, et al., editors. Advances in surgical pathology. Lung cancer, Ch 29. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 275–87.Google Scholar
  10. 10.
    Travis WD. Lung. In: Henson DE, Albores-Saavedra J, editors. Pathology of incipient neoplasia. New York: Oxford University Press; 2001. p. 295–316.Google Scholar
  11. 11.
    Woolner LB, Fontana RS, Cortese DA, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc. 1984;59:453–66.PubMedGoogle Scholar
  12. 12.
    Carter D, Marsh BR, Baker RR, et al. Relationship of morphology to clinical presentation in ten cases of early squamous cell carcinoma of the lung. Cancer. 1976;37:1389–96.PubMedCrossRefGoogle Scholar
  13. 13.
    Nagamoto N, Saito Y, Sato M, et al. Clinicopathological analysis of 19 cases of isolated carcinoma in situ of the bronchus. Am J Surg Pathol. 1993;17:1234–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Lam S, MacAulay C, LeRiche JC, et al. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer. 2000;89:2468–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Banerjee AK, Rabbitts PH, George J. Lung cancer 3: fluorescence bronchoscopy: clinical dilemmas and research opportunities. Thorax. 2003;58:266–71.PubMedCrossRefGoogle Scholar
  16. 16.
    Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial lesions by fluorescence bronchoscopy. Chest. 1998;113:696–702.PubMedCrossRefGoogle Scholar
  17. 17.
    George JP, Banerjee AK, Read CA, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax. 2007;62:43–50.CrossRefGoogle Scholar
  18. 18.
    Banerjee AK. Preinvasive lesions of the bronchus. J Thorac Oncol. 2009;4:545–51.PubMedCrossRefGoogle Scholar
  19. 19.
    Nicholson AG, Perry LJ, Cury PM, et al. Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation. Histopathology. 2001;38:202–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Venmans BJ, Van der Linden JC, Elbers JRJ, et al. Observer variability in histopathological reporting of bronchial biopsy specimens: influence on the results of autofluorescence bronchoscopy in detection of bronchial neoplasia. J Bronchol. 2000;7:210–4.CrossRefGoogle Scholar
  21. 21.
    Meert A-P, Feoli F, Martin B, et al. Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGFR expression. Histopathology. 2007;50:311–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Muller KM, Muller G. The ultrastructure of preneoplastic changes in the bronchial mucosa. Curr Top Pathol. 1983;73:233–63.PubMedCrossRefGoogle Scholar
  23. 23.
    Keith RL, Miller YE, Gemmill RM, et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res. 2000;6:1616–25.PubMedGoogle Scholar
  24. 24.
    Kerr KM, Popper HH. The differential diagnosis of pulmonary pre-invasive lesions. Eur Respir Mon. 2007;39:37–62.CrossRefGoogle Scholar
  25. 25.
    Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol. 2002;26:767–73.PubMedCrossRefGoogle Scholar
  26. 26.
    Noguchi M. Stepwise progression of pulmonary adenocarcinoma—clinical and molecular implications. Cancer Metastasis Rev. 2010;29:15–21.PubMedCrossRefGoogle Scholar
  27. 27.
    Kerr KM. Atypical adenomatous hyperplasia. In: Cagle PT, Allen TC, Dacic S, et al., editors. Advances in surgical pathology. Lung cancer, Ch 29. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 245–262.Google Scholar
  28. 28.
    Miller RR, Nelems B, Evans KG, et al. Glandular neoplasia of the lung. A proposed analogy to colonic tumours. Cancer. 1988;61:1009–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Sterner DJ, Masuko M, Roggli VL, et al. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. Mod Pathol. 1997;10:469–73.PubMedGoogle Scholar
  30. 30.
    Yokose T, Ito Y, Ochiai A. High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. Lung Cancer. 2000;29:125–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Yokose T, Doi M, Tanno K, et al. Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer. 2001;33:155–61.PubMedCrossRefGoogle Scholar
  32. 32.
    Weng S-Y, Tsuchiya E, Kasuga T, et al. Incidence of atypical bronchioloalveolar cell hyperplasia of the lung: relation to histological subtypes of lung cancer. Virchows Arch A Pathol Anat Histopathol. 1992;420:463–71.PubMedCrossRefGoogle Scholar
  33. 33.
    Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol. 1990;14:904–12.PubMedCrossRefGoogle Scholar
  34. 34.
    Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer. 2000;83:632–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Nakahara R, Yokose T, Nagai K, et al. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Thorax. 2001;56:302–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Koga T, Hashimoto S, Sugio K, et al. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia. Am J Clin Pathol. 2002;117:464–70.PubMedCrossRefGoogle Scholar
  37. 37.
    Anami Y, Matsuno Y, Yamada T, et al. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia. Pathol Int. 1998;48:634–40.PubMedCrossRefGoogle Scholar
  38. 38.
    Dohmoto K, Fujita J, Ohtsuki Y, et al. Synchronous four primary lung adenocarcinoma associated with multiple atypical adenomatous hyperplasia. Lung Cancer. 2000;27:125–30.PubMedCrossRefGoogle Scholar
  39. 39.
    Suzuki K, Takahashi K, Yoshida J, et al. Synchronous double primary lung carcinomas associated with multiple atypical adenomatous hyperplasia. Lung Cancer. 1998;19:131–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Kishi K, Homma S, Kurosaki A, et al. Multiple atypical adenomatous hyperplasia with synchronous multiple primary bronchioloalveolar carcinomas. Intern Med. 2002;41:474–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Seki M, Akasaka Y. Multiple lung adenocarcinomas and AAH treated by surgical resection. Lung Cancer. 2007;55:237–40.PubMedCrossRefGoogle Scholar
  42. 42.
    Takigawa N, Segawa Y, Nakata M, et al. Clinical investigation of atypical adenomatous hyperplasia of the lung. Lung Cancer. 1999;25:115–21.PubMedCrossRefGoogle Scholar
  43. 43.
    Kerr KM, Devereux G, Chapman AD, et al. Is survival after surgical resection of lung cancer influenced by the presence of atypical adenomatous hyperplasia (AAH)? J Thorac Oncol. 2007;2 Suppl 4:S401–2.CrossRefGoogle Scholar
  44. 44.
    Noguchi M, Morokawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844–52.PubMedCrossRefGoogle Scholar
  45. 45.
    Minami Y, Matsuno Y, Iijima T, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer. 2005;48:339–48.PubMedCrossRefGoogle Scholar
  46. 46.
    Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003;75:1601–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer. 2001;33:17–25.PubMedCrossRefGoogle Scholar
  48. 48.
    Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and ct imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279–87.PubMedCrossRefGoogle Scholar
  49. 49.
    Kerr KM. Pulmonary adenocarcinomas: classification and reporting. Histopathology. 2009;54:12–27.PubMedCrossRefGoogle Scholar
  50. 50.
    Aguayo SM, Miller YE, Waldron JA, et al. Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airway disease. N Engl J Med. 1992;327:1285–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax. 2007;62:248–52.PubMedCrossRefGoogle Scholar
  52. 52.
    Brown MJ, English J, Muller NL. Bronchiolitis ­obliterans due to neuroendocrine hyperplasia: high-resolution CT-pathologic correlation. Am J Roent­genol. 1997;168:1561–2.Google Scholar
  53. 53.
    Miller RR, Muller NL. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumours. Am J Surg Pathol. 1995;19:653–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Churg A, Warnock ML. Pulmonary tumourlet. A form of peripheral carcinoid. Cancer. 1976;37:1469–77.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Pathology, Aberdeen Royal InfirmaryAberdeen University Medical SchoolAberdeenUK

Personalised recommendations